Usefulness of endothelin-1 assessment in acute myocardial infarction;Utilidad de la determinación de endotelina-1 en el infarto agudo de miocardio

Revista Espanola de Cardiologia

Volumn 64, Issue 2, 2011, Pages 105-110

  Freixa, Xavier ^a   Heras, Magda ^a   Ortiz, José T ^a   Argiró, Sergio ^a   Guasch, Eduard ^a   Doltra, Adelina ^a   Jiménez, Marcelo ^a   Betriu, Amadeo ^a   Masotti, Mónica ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acute myocardial infarction; Endothelin; Microcirculation; Microvascular obstruction; Reperfusion injury

Indexed keywords

ENDOTHELIN 1;

ACUTE HEART INFARCTION; ADULT; ANGIOGRAPHY; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTOR VARIABLE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CAPILLARIES; ELECTROCARDIOGRAPHY; ENDOTHELIN-1; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 79951721475     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2010.07.001     Document Type: Article

References (32)

1. H. Ito, A. Okamura, K. Iwakura, T. Masuyama, M. Hori, and S. Takiuchi Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction Circulation. 93 1996 1993 1999
2. H. Ito, T. Tomooka, N. Skai, H. Yu, Y. Higashino, and K. Fujii Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction Circulation. 85 1992 1699 1705
3. H. Ito, A. Maruyama, K. Iwakura, S. Takiuchi, T. Masuyama, and M. Hori Clinical Implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction Circulation. 93 1996 223 228
4. D. Brosh, A.R. Assali, A. Mager, A. Porter, D. Hasdai, and I. Teplitsky Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality Am J Cardiol. 99 2007 442 445
5. J.V. Monmeneu, V. Bodí, J. Sanchis, M.P. López-Lereu, L. Mainar, and L. Núñez Valoración del edema tras un infarto agudo de miocardio con elevación del ST mediante resonancia magnética cardiaca Rev Esp Cardiol. 62 2009 858 866
6. S.M. Férez Santander, M.F. Márquez, M.A. Peña Duque, R. Ocaranza Sánchez, E. De la Peña Almaguer, and G. Eid Lidt Daño miocárdico por repercusión Rev Esp Cardiol. 57 Suppl 1 2004 9 21
7. S.H. Rezkalla, and R.A. Kloner No-reflow phenomenon Circulation. 105 2002 656 662
8. I. Morishima, T. Sone, K. Okumura, H. Tsuboi, J. Kondo, and H. Mukawa Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction J Am Coll Cardiol. 36 2000 1202 1209
9. T. Reffelmann, and R.A. Kloner The 'no-reflow' phenomenon: basic science and clinical correlates Heart. 87 2002 162 168
10. M. Yanagisawa, H. Kurihara, S. Kimura, K. Goto, and T. Masaki A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature. 332 1988 411 415
11. E.R. Levin Endothelins. N Engl J Med. 333 1995 356 363
12. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, and Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature. 332 1988 411 415
13. A. López Farre, A. Riesco, G. Espinosa, E. Digiuni, M.R. Cernadas, and V. Álvarez Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart Circulation. 88 1993 1166 1171
14. Y. Hayasaki, M. Nakajima, Y. Kitano, T. Iwasaki, T. Shimamura, and K. Iwaki ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype Biochem Biophys Res Commun. 229 1996 817 824
15. D.J. Stewart, G. Kubac, K.B. Costello, and P. Cernacek Increased plasma endothelin-1 in early hours of acute myocardial infarction J Am Coll Cardiol. 18 1991 38 43
16. H.K. Yip, C.J. Wu, H.W. Chang, C.H. Yang, T.H. Yu, and Y.H. Chen Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty Chest. 127 2005 1491 1497
17. Q.Y. Zhang, J.B. Ge, J.H. Zhu, J.Z. Chen, L.H. Zhang, and J.Y. Qian The relationship between endothelin-1 and tumor necrosis-alpha and myocardial microcirculation dysfunction Zhonghua Xin Xue Guan Bing Za Zhi. 34 2006 635 638
18. Q.Y. Zhang, J.B. Ge, J.H. Zhu, Q.G. Zhang, L.H. Zhang, and J.Y. Qian Effect of acute coronary microembolization on microvascular injury and myocardial endothelin-1 levels Zhonghua Xin Xue Guan Bing Za Zhi. 34 2005 538 541
19. G. Niccoli, G.A. Lanza, S. Shaw, E. Romagnoli, D. Gioia, and F. Burzotta Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization Eur Heart J. 27 2006 1793 1798
20. I. Eitel, M. Nowak, C. Stehl, V. Adams, G. Fuernau, and L. Hildebrand Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging Am Heart J. 159 2010 882 890
21. TIMI study group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med. 1985;312:932-36.
22. A.W. Van't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. De Boer, and F. Zijlstra Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction; myocardial blush grade Circulation. 97 1998 2302 2306 (Pubitemid 28280383)
23. K.P. Rentrop, M. Cohen, H. Blanke, and P.A. Phillips Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects J Am Coll Cardiol. 5 1985 587 592
24. E.L. Alderman, and M. Stadius The angiographic definitions of the Bypass Angioplasty Revascularization Investigation Coronary Artery Dis. 3 1992 1189 1207
25. J.T. Ortiz-Pérez, S.N. Meyers, D.C. Lee, P. Kansal, F.J. Klocke, and T.A. Holly Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging Eur Heart J. 28 2007 1750 1758
26. G. Tarantini, A. Ramondo, F. Corbetti, M. Perazzolo Marra, L. Cacciavillani, and M. Napodano Periprocedural abciximab administration in ST elevation myocardial infarction patients. Effect on severe microvascular obstruction beyond the restoration of epicardial coronary flow by primary angioplasty Cardiology. 110 2008 129 134
27. S.J. Valero, R. Moreno, R.M. Reyes, A.S. Recalde, G. Galeote, and L. Calvo Pharmacological approach of no-reflow phenomenon related with percutaneous coronary interventions Cardiovasc Hematol Agents Med Chem. 6 2008 125 129
28. T. Svilaas, P.J. Vlaar, I.C. Van der Horst, G.F. Diercks, B.J. De Smet, and A.F. Van den Heuvel Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med. 358 2008 557 567
29. S.Q. Khan, O. Dhillon, J. Struck, J. Struck, P.A. Quinn, and N.G. Morgenthaler C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study Am Heart J. 154 2007 736 742 (Pubitemid 47429589)
30. A.D. Singh, S. Amit, O.S. Kumar, M. Rajan, and M. Mukesh Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats Basic Clin Pharmacol Toxicol. 98 2006 604 610
31. L. Galiuto, A.N. DeMaria, U. Del Balzo, K. May-Newman, S.F. Flaim, and P.L. Wolf Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography Circulation. 102 2000 3111 3116
32. K. Trescher, M. Bauer, W. Dietl, S. Hallström, N. Wick, and M. Wolfsberger Improved myocardial protection in the failing heart by selective endothelin-A receptor blockade J Thorac Cardiovasc Surg. 137 2009 1005 1011